Clinical trial
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome: the Randomized, Multicenter, Double-blind ELECTRA RCT Study
NCT04718025 is registered in ClinicalTrials.gov with Collegium Medicum w Bydgoszczy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome: the Randomized, Multicenter, Double-blind ELECTRA RCT Study
- Lead sponsor
- Collegium Medicum w Bydgoszczy
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 7, 2022
- Completion date
- June 30, 2024
- Enrollment
- 4,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nstemi, stemi, unstable angina